| Liu, zhihong |
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( ) |
|
|
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | IVA337, Lanifibranor, Placebo | Inventiva Pharma | NASH - Nonalcoholic Steatohepatitis | 09/25 | 09/26 | | |
NCT06221059: Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease |
|
|
| Recruiting | 2 | 180 | RoW | HRS-1780 tablet；Henagliflozin Proline tablet；HRS-1780 tablet placebo ；Henagliflozin Proline tablet placebo | Shandong Suncadia Medicine Co., Ltd. | Chronic Kidney Disease | 12/24 | 04/25 | | |
NCT05847920: Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy |
|
|
| Recruiting | 2 | 76 | RoW | SHR-2010 Injection, Placebo | Guangdong Hengrui Pharmaceutical Co., Ltd | Primary IgA Nephropathy | 01/26 | 04/26 | | |
NCT05846347: Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus |
|
|
| Recruiting | 1 | 15 | RoW | GC012F injection, CD19-BCMA CAR-T cells | Zhejiang University, Gracell Biotechnology Shanghai Co., Ltd. | CAR-T | 10/23 | 04/25 | | |
NCT06285279: FKC288 in Participants With Autoimmune Kidney Diseases |
|
|
| Recruiting | 1 | 24 | RoW | FKC288 | Nanjing University School of Medicine | Lupus Nephritis, ANCA-associated Vasculitis, Membranous Nephropathy - PLA2R Induced, IgG4-Related Diseases | 12/26 | 12/28 | | |
NCT06135909: CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy |
|
|
| Recruiting | N/A | 5000 | RoW | | Chinese Pulmonary Vascular Disease Research Group | Pulmonary Hypertension | 12/27 | 12/27 | | |
NCT03161002: Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor |
|
|
| Recruiting | N/A | 400 | RoW | detection of genotype | Cui Yimin | Ticagrelor, Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Accurate Medication | 10/21 | 12/21 | | |
NCT03161496: Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants |
|
|
| Recruiting | N/A | 1200 | RoW | detection of genotype | Cui Yimin | Novel Oral Anticoagulants, NOACs, Rivaroxaban, Apixaban, Dabigatran, Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Accurate Medication | 10/21 | 12/21 | | |
NCT05569655: Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH |
|
|
| Recruiting | N/A | 100 | RoW | Tolvaptan, Samsca, Furosemide, LASâ…¨ | Chinese Pulmonary Vascular Disease Research Group | Pulmonary Arterial Hypertension, Randomized Controlled Trial | 11/22 | 12/22 | | |
PoSA-PH, NCT05595200: Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension |
|
|
| Recruiting | N/A | 480 | RoW | Level III portable sleep study | Chinese Pulmonary Vascular Disease Research Group | Sleep Apnea, Obstructive Sleep Apnea, Pulmonary Hypertension, Epidemiology, Predictor, Prognosis, Outcomes, Mortality | 12/25 | 12/25 | | |
| Recruiting | N/A | 2000 | RoW | Right heart catheterization | Chinese Pulmonary Vascular Disease Research Group | Pulmonary Hypertension, Pulmonary Arterial Hypertension | 12/24 | 12/24 | | |
NCT04210791: Autologous Stem Cell Transplantation for Patients With AL Amyloidosis |
|
|
| Enrolling by invitation | N/A | 500 | RoW | | Nanjing University School of Medicine | AL Amyloidosis, Plasma Cell Dyscrasia | 12/25 | 12/30 | | |
NCT04206852: Safety and Efficacy of Balloon Pulmonary Angioplasty in China |
|
|
| Recruiting | N/A | 200 | RoW | Balloon pulmonary angioplasty, BPA | Chinese Pulmonary Vascular Disease Research Group | Chronic Thromboembolic Pulmonary Hypertension | 05/28 | 05/28 | | |
CPETPH, NCT02061787: the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension |
|
|
| Recruiting | N/A | 4000 | RoW | balloon pulmonary angioplasty | Chinese Pulmonary Vascular Disease Research Group | Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder) | 09/30 | 09/30 | | |
NCT05388682: Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement |
|
|
| Recruiting | N/A | 200 | RoW | Percutaneous transluminal pulmonary angioplasty | Chinese Pulmonary Vascular Disease Research Group | Takayasu Arteritis With Pulmonary Artery Involvement, Percutaneous Transluminal Pulmonary Angioplasty, PAH Targeted Medication | 12/42 | 12/42 | | |
NCT05553015: A Real-World Registry Investigating TReprostInil sodiUM in Pulmonary Hypertension (Re-TRIUMPH) |
|
|
| Recruiting | N/A | 450 | RoW | | Chinese Pulmonary Vascular Disease Research Group | Pulmonary Hypertension, Medication Therapy Management | 08/25 | 12/25 | | |
